ClinicalTrials.gg
Sign In

Albuminuria clinical trials

The registry lists 142 studies for Albuminuria across more than 10 countries. 24 are recruiting or about to start. 23 of them are mainly about Albuminuria (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Albuminuria studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
85
Status unknown
19
Recruiting
12
Terminated
10
Not yet recruiting
8
Active, not recruiting
4

Phase

Phase 2
31
Phase 4
30
Phase 3
16
Early Phase 1
1
Phase 1
1

Where

United States
50
Netherlands
13
Denmark
12
Spain
10
Canada
9
Italy
8

Who runs them

University Medical Center Groningen (7) · Geisinger Clinic (5) · Steno Diabetes Center Copenhagen (5) · Novartis (4) · Medical University of Gdansk (3) · Istanbul University (2) · Peter Rossing (2) · University of Washington (2)

What is being tested here

Drugs under test in Albuminuria studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Finerenone617
Dapagliflozin419
Empagliflozin306
Semaglutide213
Canagliflozin203
Sotagliflozin202
Valsartan105
Lisinopril104
Benazepril103
Ramipril113

Drug classes tested here SGLT2 inhibitors 6 open · Mineralocorticoid receptor antagonists (MRAs) 6 open · GLP-1 receptor agonists 2 open · ACE inhibitors 1 open · Angiotensin receptor blockers (ARBs) 1 open

Coming up

1phase 3 study under way
12studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 12 Albuminuria studies recruiting now, 3 (25%) set no upper age limit and 5 (42%) stop at 75 or younger. 3 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (17%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
101 (8%)1 (8%)
1810 (83%)10 (83%)
308 (67%)8 (67%)
408 (67%)8 (67%)
509 (75%)9 (75%)
658 (67%)8 (67%)
757 (58%)7 (58%)
855 (42%)5 (42%)

Across all 142 studies, recruiting or not: 32% stop at 75 or younger and 10% at 65; 5% take children; 0% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Albuminuria studies take

Of 22 interventional studies with no phase under Albuminuria, half reached primary completion within 28 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase28 mo21–48 · 22 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 142. Browse all 142 → or search them.